Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues:
Premiums	$ 64,070	$ 55,486
Investment and other income	367	452
Total revenues	80,149	70,196
Operating costs:
Medical costs	52,523	44,904
Operating costs	11,401	10,223
Cost of products sold	8,487	7,572
Depreciation and amortization	788	758
Total operating costs	73,199	63,457
Earnings from operations	6,950	6,739
Interest expense	(433)	(397)
Earnings before income taxes	6,517	6,342
Provision for income taxes	(1,369)	(1,364)
Net earnings	5,148	4,978
Earnings attributable to noncontrolling interests	(121)	(116)
Net earnings attributable to UnitedHealth Group common shareholders	$ 5,027	$ 4,862
Earnings per share attributable to UnitedHealth Group common shareholders:
Basic	$ 5.34	$ 5.14
Diluted	$ 5.27	$ 5.08
Basic weighted-average number of common shares outstanding	941	945
Dilutive effect of common share equivalents	13	12
Diluted weighted-average number of common shares outstanding	954	957
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	2	3
Products
Revenue from Products and Services	$ 9,340	$ 8,340
Services
Revenue from Products and Services	$ 6,372	$ 5,918